E
Amicus Therapeutics, Inc. FOLD
$7.61 $0.010.13% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -38.10M -29.37M -56.11M -104.69M -119.54M
Total Depreciation and Amortization 7.90M 8.23M 8.55M 8.69M 8.75M
Total Amortization of Deferred Charges 2.41M 2.34M 2.26M 2.20M 2.35M
Total Other Non-Cash Items 92.89M 92.98M 110.35M 121.79M 109.82M
Change in Net Operating Assets -110.76M -70.62M -98.94M -54.51M -43.27M
Cash from Operations -45.66M 3.56M -33.89M -26.52M -41.89M
Capital Expenditure -3.26M -1.95M -3.55M -5.00M -6.21M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -21.50M -39.00M 2.99M 871.00K 3.57M
Cash from Investing -24.76M -40.96M -560.00K -4.13M -2.63M
Total Debt Issued -- -- -- 387.36M 387.36M
Total Debt Repaid -42.00K -70.00K -97.00K -408.29M -408.35M
Issuance of Common Stock 23.07M 23.89M 27.24M 57.52M 76.56M
Repurchase of Common Stock -15.84M -17.09M -22.03M -22.76M -22.32M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -1.59M -1.59M
Cash from Financing 7.19M 6.73M 5.12M 12.23M 31.66M
Foreign Exchange rate Adjustments 12.89M 2.60M -4.03M -11.04M 10.89M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -50.34M -28.06M -33.36M -29.45M -1.98M